FDA Clears bioMérieux System for Microbial Identification and Susceptibility Testing
The automated VITEK PRO platform will replace VITEK 2 and VITEK XL, with a US commercial launch planned for early 2027.
Latest Articles
Editor's Top Picks
UW Medicine Implements Roche’s Automated Mass Spectrometry Platform for Patient Testing
The system began patient testing Nov 2, initially focusing on vitamin and hormone assays, with plans to expand into therapeutic drug monitoring and toxicology.
Be the First to Know What’s Next in the Lab
Every week, we dig into the biggest shifts, breakthroughs, and tech transforming clinical diagnostics. Straightforward, insightful, and always relevant.Critical Resources
Diagnostic Innovations
BIOTYPE and APIS Partner to Commercialize Two Cancer-Related Molecular Tests
The agreement covers an ESR1 mutation detection kit for metastatic breast cancer and a DPYD genotyping kit for assessing chemotherapy toxicity risk.
Equipment & Supply Spotlight
DNA/RNA Extraction Kit Designed to Simplify Molecular Testing Receives CE-IVD Mark
The kit allows laboratories to extract DNA and RNA from a range of clinical specimens using a single method.
News, Know-How & Standards
Disease Detection & Understanding
New Sequencing Panel Aims to Bring Leukemia Monitoring Into More Labs
The research-use-only assay combines two key genetic markers for acute myeloid leukemia in a single test, potentially reducing the need for separate testing workflows and reference lab send-outs.
